tiprankstipranks
Trending News
More News >
Insight Molecular Diagnostics (IMDX)
NASDAQ:IMDX

Compare Insight Molecular Diagnostics (IMDX) vs. Competitors

Compare
431 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Insight Molecular Diagnostics
$7.50
$214.98M
-2.65
236.32%
2 Buy
1 Hold
0 Sell
Moderate Buy
Atossa Therapeutics
$0.65
$84.35M
-2.78
-29.33%
4 Buy
0 Hold
0 Sell
Strong Buy
MacroGenics
$1.79
$113.23M
-1.48
-46.57%
1 Buy
3 Hold
0 Sell
Hold
Elutia
$0.64
$29.49M
-0.75
-79.71%
2 Buy
0 Hold
0 Sell
Moderate Buy
Surrozen
$19.06
$163.37M
-0.87
48.79%
3 Buy
0 Hold
0 Sell
Strong Buy
Telomir Pharmaceuticals, Inc.
$1.35
$48.82M
-3.80
-66.98%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMDX
Insight Molecular Diagnostics
7.50
5.42
260.58%
ATOS
Atossa Therapeutics
0.65
-0.27
-29.02%
MGNX
MacroGenics
1.79
-1.38
-43.53%
ELUT
Elutia
0.69
-2.44
-77.96%
SRZN
Surrozen
19.06
7.74
68.37%
TELO
Telomir Pharmaceuticals, Inc.
1.42
-3.08
-68.44%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts